Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.05M Buy
18,438
+3,746
+25% +$383K 0.51% 58
2022
Q3
$1.26M Buy
14,692
+1,981
+16% +$177K 0.27% 66
2022
Q2
$1.16M Buy
12,711
+10
+0.1% +$887 0.25% 66
2022
Q1
$1.04M Sell
12,701
-18
-0.1% -$1.42K 0.17% 83
2021
Q4
$975K Sell
12,719
-162
-1% -$12.9K 0.14% 79
2021
Q3
$968K Buy
12,881
+3
+0% +$228 0.14% 73
2021
Q2
$1M Sell
12,878
-1,165
-8% -$86.7K 0.15% 77
2021
Q1
$1.03M Sell
14,043
-239
-2% -$17.6K 0.17% 74
2020
Q4
$1.11M Buy
14,282
+340
+2% +$26K 0.19% 76
2020
Q3
$1.07M Buy
13,942
+215
+2% +$16.8K 0.2% 77
2020
Q2
$1.06M Sell
13,727
-267
-2% -$20.1K 0.23% 75
2020
Q1
$1.02M Buy
13,994
+245
+2% +$19.3K 0.27% 73
2019
Q4
$1.18M Buy
13,749
+1
+0% +$82 0.33% 71
2019
Q3
$1.09M Buy
13,748
+538
+4% +$43.1K 0.38% 59
2019
Q2
$1.05M Hold
13,210
0.44% 54
2019
Q1
$1.01M Sell
13,210
-156
-1% -$11.7K 0.43% 55
2018
Q4
$1.02M Buy
13,366
+599
+5% +$42.3K 0.53% 48
2018
Q3
$930K Buy
12,767
+779
+6% +$49.6K 0.52% 53
2018
Q2
$694K Buy
11,988
+3,205
+36% +$181K 0.4% 66
2018
Q1
$457K Sell
8,783
-2,148
-20% -$116K 0.3% 73
2017
Q4
$587K Buy
+10,931
New +$606K 0.38% 70

Other funds holding MRK

Burleson & Co's MRK Position: Q4 2022 in Review

Burleson & Co increased its Merck (MRK) stake by 25% in Q4 2022, buying an estimated $383K and bringing the position to 18,438 shares worth $2.05M. The position accounts for 0.51% of the portfolio, ranked #58.

Burleson & Co first reported a position in MRK in Q4 2017 and has held it in 21 quarters since. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Burleson & Co held 18,438 shares of Merck worth $2.05M as of Q4 2022.
  • Burleson & Co bought 3,746 Merck shares in Q4 2022, an estimated $383K.
  • Merck made up 0.51% of Burleson & Co's portfolio in Q4 2022, its #58 holding.
  • Burleson & Co first reported a position in Merck in Q4 2017 and has held it in 21 quarters since.
  • 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.